title: [Topical immunomodulation in the treatment of herpetic infections in HIV-infected patients].
abstract: The efficiency of cycloferon liniment in combined treatment of herpetic infection in patients with latent form of HIV infection has been assess by observations of 40 patients divided into two groups. In the first group, the standard treatment was supplemented with the application of cycloferon liniment twice a day during 7 days; in the second group, the therapy was conducted according to standard recommendations. It was established that the application of cycloferon liniment in combination with standard therapy in patients with relapse of herpetic infection against the background of HIV infection ensures faster disappearance of general infectious syndrome, decreases the period of eruptions and the duration of local inflammations, and accelerates the epithelialization of erosions.
authors: A A
authors: AA
authors: Shul'diakov
authors: T S
authors: TS
authors: Barkhatova
authors: E V
authors: EV
authors: Zubareva
authors: S A
authors: SA
authors: Satarova
authors: T A
authors: TA
authors: Perminova
mesh_terms: D000166:Acridines / Q000494:pharmacology / Q000627:therapeutic use*; D000287:Administration, Topical; D000328:Adult; D060085:Coinfection; D004359:Drug Therapy, Combination; D005260:Female; D006678:HIV / Q000187:drug effects* / Q000502:physiology; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D006561:Herpes Simplex / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D006564:Herpesviridae / Q000187:drug effects* / Q000276:immunology; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology / Q000627:therapeutic use*; D008038:Liniments; D008297:Male; D017735:Virus Latency
chemical_list: D000166:Acridines; D007155:Immunologic Factors; D008038:Liniments; C026430:10-carboxymethyl-9-acridanone